Delaney Program to Cure HIV
Delaney AIDS Research Enterprise to Cure HIV
This program aims to find new ways to reduce the amount of HIV in the body or help people control the virus without needing daily medication.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11085936 on NIH RePORTER |
What this research studies
Our team is working to develop new combination treatments that can either significantly lower the amount of HIV hidden in the body or help the immune system keep the virus under control even when antiretroviral therapy (ART) is stopped. We are focusing on strengthening the body's natural defenses to fight the virus early on, before it can spread widely. Additionally, we are exploring ways to make HIV-infected cells more vulnerable so the body can clear them, potentially leading to a long-term remission or even a cure.
Who could benefit from this research
Good fit: Ideal candidates for future clinical opportunities related to this work would be people living with HIV who are interested in participating in advanced experimental therapies.
Not a fit: Patients who do not have HIV or those not suitable for experimental treatments would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new therapies that allow people with HIV to achieve long-term control of the virus without daily medication, or even a functional cure.
How similar studies have performed: This work builds upon novel observations made by our research group, aiming to prove new strategies for HIV remission and cure.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Deeks, Steven Grant — University of California, San Francisco
- Study coordinator: Deeks, Steven Grant
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.